We are live on ! Find out more
PI

Putnam Investments Portfolio holdings

AUM $75.7B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+34.45%
3 Year Est. Return
+61.95%
5 Year Est. Return
+203.43%
10 Year Est. Return
+442.91%
AUM
$57.3B
AUM Growth
+$4.7B
Cap. Flow
+$341M
Cap. Flow %
0.6%
Top 10 Hldgs %
23.03%
Holding
1,248
New
109
Increased
395
Reduced
589
Closed
114

Top Buys

Rank Stock Value
1
VNO icon
Vornado Realty Trust
VNO
+$210M
2
TMUS icon
T-Mobile US
TMUS
+$169M
3
AMAT icon
Applied Materials
AMAT
+$148M
4
ORCL icon
Oracle
ORCL
+$144M
5
AVGO icon
Broadcom
AVGO
+$140M

Sector Composition

Rank Sector Weight
1 Healthcare 19.01%
2 Technology 18.94%
3 Financials 13.73%
4 Industrials 9.87%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRI icon
851
Herc Holdings
HRI
$5.71B
$454K ﹤0.01%
3,453
-296
-8% -$36.4K
B
852
DELISTED
Barnes Group Inc.
B
$451K ﹤0.01%
11,051
-5
-0% -$187
OEC icon
853
Orion
OEC
$391M
$450K ﹤0.01%
25,250
-15
-0.1% -$252
FL
854
DELISTED
Foot Locker
FL
$447K ﹤0.01%
11,823
+2,301
+24% +$78.9K
IBM icon
855
IBM
IBM
$223B
$447K ﹤0.01%
3,171
-1,169
-27% -$161K
USB icon
856
US Bancorp
USB
$99.7B
$446K ﹤0.01%
10,232
+4,945
+94% +$212K
AMSF icon
857
AMERISAFE
AMSF
$521M
$445K ﹤0.01%
8,558
-5
-0.1% -$265
HTH icon
858
Hilltop Holdings
HTH
$2.22B
$443K ﹤0.01%
14,778
-8
-0.1% -$228
CINC
859
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$439K ﹤0.01%
+35,728
New +$851K
CCO icon
860
Clear Channel Outdoor Holdings
CCO
$1.23B
$439K ﹤0.01%
+417,941
New +$526K
WTS icon
861
Watts Water Technologies
WTS
$12.9B
$434K ﹤0.01%
2,968
-1
-0% -$144
MYRG icon
862
MYR Group
MYRG
$5.19B
$433K ﹤0.01%
4,699
-420
-8% -$38.1K
RAPT
863
DELISTED
RAPT Therapeutics
RAPT
$432K ﹤0.01%
2,727
-1
-0% -$160
CDP icon
864
COPT Defense Properties
CDP
$4.14B
$431K ﹤0.01%
16,613
-9
-0.1% -$231
NHI icon
865
National Health Investors
NHI
$3.59B
$430K ﹤0.01%
8,233
-4
-0% -$219
JBSS icon
866
John B. Sanfilippo & Son
JBSS
$962M
$430K ﹤0.01%
5,285
-2
-0% -$163
CEVA icon
867
CEVA Inc
CEVA
$910M
$429K ﹤0.01%
16,786
-9
-0.1% -$242
CRNX icon
868
Crinetics Pharmaceuticals
CRNX
$8.93B
$427K ﹤0.01%
23,338
-13
-0.1% -$229
ICPT
869
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$423K ﹤0.01%
34,236
+2,491
+8% +$35.3K
MCFT icon
870
MasterCraft Boat Holdings
MCFT
$586M
$422K ﹤0.01%
16,318
-9
-0.1% -$212
DGX icon
871
Quest Diagnostics
DGX
$26.1B
$421K ﹤0.01%
+2,694
New +$387K
AVA icon
872
Avista
AVA
$3.19B
$421K ﹤0.01%
9,489
+1,023
+12% +$40.9K
ACAD icon
873
Acadia Pharmaceuticals
ACAD
$5.05B
$420K ﹤0.01%
26,390
-14
-0.1% -$219
CMBM
874
DELISTED
Cambium Networks
CMBM
$420K ﹤0.01%
19,373
-2,081
-10% -$42K
KTB icon
875
Kontoor Brands
KTB
$4.26B
$420K ﹤0.01%
10,492
-5
-0% -$195

Similar funds

Putnam Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Putnam Investments held 1,248 positions worth $57.3B, up 8.9% from $52.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Putnam Investments's Q4 2022 filing shows 109 new, 395 increased, 589 reduced and 114 closed positions. Its largest new stake was Pinduoduo: 209,422 shares worth $17.1M. The largest sale was Enterprise Products Partners, an estimated $172M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • Putnam Investments's largest Q4 2022 buy was Pinduoduo: 209,422 shares worth $17.1M.
  • Putnam Investments added most to Vornado Realty Trust in Q4 2022, an estimated $210M increase.
  • Putnam Investments's biggest Q4 2022 reduction was Enterprise Products Partners, cutting an estimated $172M.
  • Putnam Investments fully exited Marvell Technology in Q4 2022, selling an estimated $63.9M.
  • Putnam Investments's ten largest holdings make up 23% of its $57.3B portfolio in Q4 2022.
  • Putnam Investments opened 109 new positions and closed 114 in Q4 2022.
  • Putnam Investments's portfolio value rose 8.9% quarter-over-quarter to $57.3B.

Based on Putnam Investments's 13F filing for Q4 2022, filed 14 Feb 2023.